Lonza Group AG (LON:0QNO)
547.40
-15.80 (-2.81%)
Mar 31, 2025, 1:44 PM BST
Lonza Group AG Revenue
In the year 2024, Lonza Group AG had annual revenue of 6.57B CHF, down -2.13%. Lonza Group AG had revenue of 3.52B in the half year ending December 31, 2024, with 8.52% growth.
Revenue
6.57B CHF
Revenue Growth
-2.13%
P/S Ratio
n/a
Revenue / Employee
351.81K CHF
Employees
18,686
Market Cap
35.50B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.57B | -143.00M | -2.13% |
Dec 31, 2023 | 6.72B | 494.00M | 7.94% |
Dec 31, 2022 | 6.22B | 814.00M | 15.05% |
Dec 31, 2021 | 5.41B | 901.00M | 19.99% |
Dec 31, 2020 | 4.51B | 301.00M | 7.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Lonza Group AG News
- 7 weeks ago - Lonza Group Appears To Be Fully Valued At This Time (Rating Downgrade) - Seeking Alpha
- 2 months ago - Lonza Posts Lower Sales, Earnings But Expects Capsules Business Rebound This Year - The Wall Street Journal
- 8 months ago - Lonza Group AG (LZAGY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Lonza Group AG (LZAGY) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Lonza: Acceleration In Mid-Term Sales Growth - Seeking Alpha
- 1 year ago - Lonza: Excellent Growth Projections Will Sharply Increase Free Cash Flow - Seeking Alpha
- 1 year ago - Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Lonza chairman to step down, drugmaker confirms targets, shares soar - Reuters